| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/2011 | WO2011084503A1 Phenoxy thiophene sulfonamides and their use in the treatment of neurodegenerative diseases |
| 07/14/2011 | WO2011084486A1 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 07/14/2011 | WO2011084473A1 Non-irritating ophthalmic povidone-iodine compositions |
| 07/14/2011 | WO2011084459A1 Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases |
| 07/14/2011 | WO2011084456A1 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases |
| 07/14/2011 | WO2011084455A2 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1 |
| 07/14/2011 | WO2011084453A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases |
| 07/14/2011 | WO2011084439A1 Tetrahydrocarboline derivatives as eg5 inhibitors |
| 07/14/2011 | WO2011084437A1 Mglu2 agonists |
| 07/14/2011 | WO2011084434A2 Aza-ring fused indole and indoline derivatives |
| 07/14/2011 | WO2011084433A2 Aza-bridged ring-fused indoles and indolines |
| 07/14/2011 | WO2011084371A1 Aminobenzoquinazolinone m1 receptor positive allosteric modulators |
| 07/14/2011 | WO2011084368A1 Quinoline amide m1 receptor positive allosteric modulators |
| 07/14/2011 | WO2011084366A2 Methods, compositions and drug delivery systems for intraocular delivery of sirna molecules |
| 07/14/2011 | WO2011084357A1 Modulation of pilr to treat immune disorders |
| 07/14/2011 | WO2011084106A1 Novel amphiphiles |
| 07/14/2011 | WO2011084046A1 Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atherosclerosis and cardiovascular disease |
| 07/14/2011 | WO2011083999A2 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
| 07/14/2011 | WO2011083998A2 Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient |
| 07/14/2011 | WO2011083853A1 Anti-atopic dermatitis agent |
| 07/14/2011 | WO2011083830A1 Novel anticancer agent and method for screening same |
| 07/14/2011 | WO2011083827A1 Cerebral nerve cell neogenesis agent |
| 07/14/2011 | WO2011083823A1 Prophylactic or therapeutic agent for schizophrenia |
| 07/14/2011 | WO2011083804A1 Indole derivative |
| 07/14/2011 | WO2011083787A1 Anti-inflammatory analgesic adhesive patch for external use |
| 07/14/2011 | WO2011083718A1 Agent for promoting lung regeneration |
| 07/14/2011 | WO2011083637A1 Therapeutic agent for hepatic disorder |
| 07/14/2011 | WO2011083490A2 Stable veterinary composition for enhanced phosphorous uptake |
| 07/14/2011 | WO2011083487A1 Sulfone compounds as 5-ht6 receptor ligands |
| 07/14/2011 | WO2011083413A1 Piperazines as antimalarial agents |
| 07/14/2011 | WO2011083402A2 Immediate release compositions of acid labile drugs |
| 07/14/2011 | WO2011083387A1 Hydrochloride salt of biphenyl-2-yl-carbamic acid 1-{9-[(3-fluoro-4-hydroxy-benzoyl)-methyl-amino]-nonyl}-piperidin-4-yl ester |
| 07/14/2011 | WO2011083316A1 Benzazepine derivatives for the treatment of central nervous system disorders |
| 07/14/2011 | WO2011083315A1 Compounds and their use |
| 07/14/2011 | WO2011083314A1 Benzazepine derivatives for the treatment of central nervous system disorders |
| 07/14/2011 | WO2011083304A1 Prodrugs of opioids and uses thereof |
| 07/14/2011 | WO2011083291A1 Combinations comprising an ant i -inflammatory agent and/or an antibacterial agent and a glycosylamine and their use in medicine |
| 07/14/2011 | WO2011083278A1 Novel benzoic pyrrolopyridine derivatives |
| 07/14/2011 | WO2011083275A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
| 07/14/2011 | WO2011083265A1 Novel derivatives of cyclopropylated benzothiadiazines, method for preparing same and pharmaceutical compositions containing same |
| 07/14/2011 | WO2011083264A1 Thiochroman derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/14/2011 | WO2011083196A1 Lipophilic phenolic derivatives as surfactants |
| 07/14/2011 | WO2011083147A1 Wave1 inhibition in the medical intervention of inflammatory diseases and/or infections caused by a pathogen |
| 07/14/2011 | WO2011083124A1 Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
| 07/14/2011 | WO2011082951A1 Combination preparations comprising a cytokine antagonist and corticosteroid |
| 07/14/2011 | WO2011082950A1 Combination preparations comprising exosomes and corticosteroid |
| 07/14/2011 | WO2011082732A1 Sphingosine kinase inhibitors |
| 07/14/2011 | WO2011082617A1 (e)-1-(3,5-dimethoxyphenyl)-2-(3,5-dihydroxy-4-methoxyphenyl)ethylene and preparation method and use thereof |
| 07/14/2011 | WO2011082519A1 Geldanamycin derivatives, preparation methods and uses thereof |
| 07/14/2011 | WO2011082488A1 Bisphenol derivative therapeutics and methods for their use |
| 07/14/2011 | WO2011082487A1 Bisphenol derivatives and their use as androgen receptor activity modulators |
| 07/14/2011 | WO2011082458A1 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with these diseases, such as cachexia, and remedying adverse effects of drugs and treatments, such as immunodepression, neutropenia and lymphocytopenia, comprising the association or combination of a specially selected biological response modifier and other antineoplastic compounds and/or other treatments |
| 07/14/2011 | WO2011061687A3 Multiple-phase dietary supplement product |
| 07/14/2011 | WO2011061610A3 Processes for preparation of polymorphic forms of lacosamide |
| 07/14/2011 | WO2011059931A3 Nanosuspension of a poorly soluble drug made by microfluidization process |
| 07/14/2011 | WO2011056744A4 IRE-1 α INHIBITORS |
| 07/14/2011 | WO2011053697A8 2-aminoindole compounds and methods for the treatment of malaria |
| 07/14/2011 | WO2011052884A3 Sustained release tablet containing theobromine |
| 07/14/2011 | WO2011050353A8 Method for treating androgen receptor positive cancers |
| 07/14/2011 | WO2011048033A3 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 07/14/2011 | WO2011042793A8 Stabilized pharmaceutical composition comprising gabapentin with minimum levels of pharmaceutically acceptable inert excipients |
| 07/14/2011 | WO2011041470A3 Sustained-release opiate and opiate derivative compositions |
| 07/14/2011 | WO2011040613A8 Therapeutic agent for tumor |
| 07/14/2011 | WO2011038924A9 Proteasome inhibitors for treating cancer |
| 07/14/2011 | WO2011037355A3 Pharmaceutical composition for treating and preventing diseases involving joints and connective tissue |
| 07/14/2011 | WO2011036676A3 Stable cocrystals of temozolomide |
| 07/14/2011 | WO2011035212A3 Role of n-2 hydroxy-ethyl-piperazine-n'-2-ethane sulfonic acid (hepes) in pain control and reversal of demyelinization injury |
| 07/14/2011 | WO2011035158A3 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
| 07/14/2011 | WO2011033265A8 Pharmaceutical compounds |
| 07/14/2011 | WO2011031111A3 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 07/14/2011 | WO2011030224A3 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities |
| 07/14/2011 | WO2011028813A3 Insulin analogues of enhanced receptor-binding specificity |
| 07/14/2011 | WO2011028737A3 Bisphosphonate compositions and methods for treating heart failure |
| 07/14/2011 | WO2011028492A3 Sortase a inhibitors |
| 07/14/2011 | WO2011028255A3 Desferrithiocin polyether analogues and uses thereof |
| 07/14/2011 | WO2011026076A3 Topical formulations comprising a steroid |
| 07/14/2011 | WO2011026060A9 Treatment and prevention of secondary injury after trauma or damage to the central nervous system |
| 07/14/2011 | WO2011026003A3 A xylitol containing comestible product |
| 07/14/2011 | WO2011025230A3 Gaba release-regulating agent in cerebellum |
| 07/14/2011 | WO2011025220A3 Liver regeneration accelerator comprising betaine |
| 07/14/2011 | WO2011022292A3 Method of treating bipolar disorder or depression using an antiestrogen |
| 07/14/2011 | WO2011021864A3 Novel compound for complementing anticancer drugs, a production method for the same, a composition for complementing anticancer drugs comprising the same, and a method for reducing resistance to anticancer drugs using the same |
| 07/14/2011 | WO2011019942A3 Synthetic cholesterylamine-linker derivatives for agent delivery into cells |
| 07/14/2011 | WO2011014883A3 Skin rejuvenation and wrinkle treatment by gingival fibroblast and its growth factor: activation of effect by hyluronic acid |
| 07/14/2011 | WO2011012746A3 Apaf-1 inhibitor compounds |
| 07/14/2011 | WO2011004040A3 Use of captopril as a cardioprotector and anti-inflammatory for heart trouble associated with arterial hypertension |
| 07/14/2011 | WO2010149578A3 Novel biphenyl and phenyl-pyridine amides |
| 07/14/2011 | WO2010144140A4 Egfr and par2 regulation of intestinal permeability |
| 07/14/2011 | WO2010106383A8 Novel crystalline form of antiprogestin cdb-4124 |
| 07/14/2011 | WO2010096564A4 Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits |
| 07/14/2011 | WO2010049709A8 Therapeutic compositions comprising phenolic acids for treating conditions related to inappropriate platelet aggregation |
| 07/14/2011 | WO2008157191A3 Quinazoline derivatives as pi3 kinase inhibitors |
| 07/14/2011 | WO2008060632A3 1' - substituted ribose 5 ' - polyphosphate analogs and their use as modulators of p2y receptor activity |
| 07/14/2011 | WO2007132314A3 Substituted piperidino phenyloxazolidinones |
| 07/14/2011 | US20110173709 Ectopic, orthotopic model for revascularization and tumor assessment |
| 07/14/2011 | US20110172583 High citrate dialysate and uses thereof |
| 07/14/2011 | US20110172580 Wound care dressing |
| 07/14/2011 | US20110172446 Methods and compositions for use in treating cancer |
| 07/14/2011 | US20110172435 Treatment Of Inflammatory Bowel Disease |
| 07/14/2011 | US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |